Early Treatment of Psoriasis: A Window Of Opportunity?

The discussion centers on the importance of early treatment for psoriasis, emphasizing that timely intervention could significantly improve patient outcomes, including quality of life and prevention of comorbidities like psoriatic arthritis and cardiovascular diseases. The speaker highlights the challenges faced by patients with chronic skin conditions and the significance of addressing them early to avoid structural changes that complicate treatment outcomes. Current research indicates that treating psoriasis within a year of onset can lead to better clinical outcomes and may even decrease mortality rates associated with severe psoriasis. The speaker presents compelling cases and studies demonstrating the effectiveness of early intervention, noting that patients with shorter disease duration tend to experience better responses to treatment. The potential role of tissue resident memory cells in the persistence of psoriasis is discussed, suggesting that early treatment might help to reshape the immune response in ways that lead to more prolonged remission. Ultimately, the speaker argues for a paradigm shift in dermatology to prioritize early treatment, not only to alleviate symptoms but also to mitigate long-term health risks.